Outpatient spine procedures have seen explosive growth over the last 10 years — a pattern that could continue as technology rapidly advances in the industry.
Upadacitinib demonstrated long-term efficacy for the treatment of ankylosing spondylitis among patients who failed to respond to prior biologic therapy.
The Company presentation and Q&A session will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on ONWARD Medical’s ...